Mesoblast Limited announced the appointment of Dr. Fred Grossman as Chief Medical Officer (CMO), based in New York. Dr. Grossman brings a wealth of commercial experience gained from numerous leadership roles at global pharmaceutical companies. The appointment aligns closely with the Company'scommercial objectives for its lead products. Dr. Grossman has over 20 years of industry experience, and has held key leadership positions at major global pharmaceutical companies, including Eli Lilly, Johnson & Johnson (J&J), Bristol Myers Squibb (BMS), Sunovion, and Glenmark.